Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristian Rodriguez

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 23, 2023
The impact of a two-year long COVID-19 public health restriction program on mechanical thrombectomy outcomes in a stroke networkRodrigo Rivera, Cristian Amudio, Juan Pablo Cruz, et al.
Oncotarget|March 5, 2015
Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growthGuillermo N Armaiz-Pena, Vianey Gonzalez-Villasana, Archana S Nagaraja, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer ModelsPinar Kanlikilicer, Bulent Ozpolat, Burcu Aslan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Molecular Cancer Therapeutics|September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse ModelsKatelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Molecular Cancer Therapeutics|October 5, 2014
Therapeutic silencing of KRAS using systemically delivered siRNAsChad V Pecot, Sherry Y Wu, Seth Bellister, et al.
International Journal of Molecular Sciences|January 27, 2024
EphA2- and HDAC-Targeted Combination Therapy in Endometrial CancerRobiya Joseph, Santosh K Dasari, Sujanitha Umamaheswaran, et al.
Stem Cell Reports|December 19, 2017
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 PathwayYi Liu, Dong Soon Choi, Jianting Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2019
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast CancersHailing Yang, Zhang Shu, Yongying Jiang, et al.
Nature Communications|September 13, 2024
HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitisAgnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 23, 2023
The impact of a two-year long COVID-19 public health restriction program on mechanical thrombectomy outcomes in a stroke networkRodrigo Rivera, Cristian Amudio, Juan Pablo Cruz, et al.
Oncotarget|March 5, 2015
Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growthGuillermo N Armaiz-Pena, Vianey Gonzalez-Villasana, Archana S Nagaraja, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer ModelsPinar Kanlikilicer, Bulent Ozpolat, Burcu Aslan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Molecular Cancer Therapeutics|September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse ModelsKatelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Molecular Cancer Therapeutics|October 5, 2014
Therapeutic silencing of KRAS using systemically delivered siRNAsChad V Pecot, Sherry Y Wu, Seth Bellister, et al.
International Journal of Molecular Sciences|January 27, 2024
EphA2- and HDAC-Targeted Combination Therapy in Endometrial CancerRobiya Joseph, Santosh K Dasari, Sujanitha Umamaheswaran, et al.
Stem Cell Reports|December 19, 2017
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 PathwayYi Liu, Dong Soon Choi, Jianting Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2019
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast CancersHailing Yang, Zhang Shu, Yongying Jiang, et al.
Nature Communications|September 13, 2024
HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitisAgnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, et al.
Pageof 15